Obstetrics, Gynecology and Reproductive Biology Research
FSAD - Women’s Health Study
This study is currently closed to enrollment.
A Phase 2b, Multi-Center, Multiple-Dose, Double-Blind, Placebo-Controlled Study To Evaluate the Efficacy And Safety Of Sildenafil Cream, 3.6% In Premenopausal Patients With Female Sexual Arousal Disorder (FSAD)
AGE: Premenopausal women, 21 +
GENDER: Female
GENDER: Female
TYPE: Interventional Treatment Study
CONDITION: Female Sexual Arousal Disorder
HEALTHY PARTICIPANTS: Yes
CONDITION: Female Sexual Arousal Disorder
HEALTHY PARTICIPANTS: Yes
DEPARTMENT: Obstetrics & Gynecology
LOCATION: UH Cleveland Medical Center
LOCATION: UH Cleveland Medical Center
Study Purpose
The purpose of this study is to find out if the investigational drug, topical Sildenafil Cream, 3.6%, increases genital arousal in women during sexual activity.